Aurora Spine (TSE:ASG) has released an update.
Aurora Spine Corporation marks the second anniversary of the revolutionary DEXA-C cervical interbody fusion device, the first to match a patient’s bone density. The device, which has been used by neurosurgeons in over 200 levels, is praised for its clear imaging and reduced MRI artefact. The company is advancing with a multicenter study to further evaluate the system’s efficacy for patients with degenerative disc disease.
For further insights into TSE:ASG stock, check out TipRanks’ Stock Analysis page.
